TBP and metabolic disease: Conventional reference genes such as GAPDH, TBP, or miR-16-5p, frequently chosen based on historical usage rather than empirical evidence, show considerable variability in contexts like cancer, metabolic disorders, and biofluids prone to hemolysis.